Lineage Corp - LCTX Company Total Asset Base

Corporate emblem and logo of Lineage Cell Therapeutics Inc (LCTX)

The current price action of Lineage Cell Therapeutics (LCTX) total assets, reaching 98.50, correlates with the recruitment of top tissue regeneration specialists through stock option programs. Lineage Cell Therapeutics (LCTX) operates based on strict GMP standards and heavy R&D investments for organ restoration. Business development relies on a strategic alliance with Roche, which fully funds the final testing stages of ophthalmology products.

Lineage Bio (LCTX) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for Lineage Bio (LCTX)

- price and consensus price forecast:
Share Price lineagecell.com|LCTX - Price Target Chart
- market capitalization data:
Market Capitalization Lineage Corp|LCTX - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share Lineage Cell Therapeutics|LCTX - Book Capitalization|Market-to-Book Ratio lineagecell.com|LCTX - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Lineage Cell Therapeutics|LCTX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Lineage Corp|LCTX - Company Aggregate Debts|Debts to Book Value Lineage Corp|LCTX - Company Long-Term Debt|Company Short-Term Debt Lineage Cell Therapeutics
General company analysis:lineagecell.com, LCTX
Manufactured product of Lineage Cell Therapeutics

For Lineage Cell Therapeutics (LCTX), the total asset value on the GURU.Markets platform reflects the overall volume of resources controlled by the company. This metric is calculated inversely via return on assets (ROA), capturing the market consensus regarding the scale of the balance sheet. The dynamics of this metric are critically sensitive to capital efficiency within costly stem cell clinical trials. Base growth without confirmed liquidity may mask an imbalance, calling into question the scalability of therapy production.

Main competitors

MESO (mesoblast.com) - Total Business Assets|SRZN: Aggregate Company Assets|Company Total Asset Base Cryo-Cell International Inc (CCEL)|Cumulative Company Assets FibroBiologics, Inc.|Aggregate Business Assets Longeveron Corporation (LGVN)|BRTX: Company Total Assets|Creative Medical Technology Holdings, Inc. - Company Assets